Annovis Bio Inc.
ANVS | NYSE
$1.26
+$0.07 (+5.88%)
Sep 22, 2026, 2:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -28.85B | -24.59B | -56.2M | -25.33M | -14.49M | -5.46M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.8B | 3.84B | 4.63M | 9.15M | 4.7M | 1.86M |
Other Working Capital | 1.29M | -331.43K | 2.44M | -4.41M | 311.13K | -440.13K |
Other Non-Cash Items | 1.44B | -1.14B | 11.84M | n/a | n/a | 27.03K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.58M | 681.71K | -228.6K | -1.14M | 657.35K | -400.71K |
Operating Cash Flow | -25.62B | -21.89B | -39.97M | -17.31M | -9.13M | -3.97M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 3 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 12.03M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 34.57B | 26.67B | 458.39K | n/a | 95.1K | n/a |
Financial Cash Flow | 34.6B | 26.69B | 17.34M | 4.61K | 46.74M | 12.04M |
Net Cash Flow | 8.98B | 4.8B | -22.62M | -17.31M | 37.61M | 8.07M |
Free Cash Flow | -25.62B | -21.89B | -39.97M | -17.31M | -9.13M | -3.97M |
Adj. Free Cash Flow | -27.42B | -25.73B | -44.6M | -26.47M | -13.83M | -5.84M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | 3 |
Owner Earnings | -25.62B | -21.89B | -39.97M | -17.31M | -9.13M | -3.97M |
Add to Watchlist
Select watchlists to add or remove ANVS